1. Targeting protein self-association in drug design.
- Author
-
UCL - SSS/LDRI - Louvain Drug Research Institute, Thabault, Léopold, Liberelle, Maxime, Frédérick, Raphaël, UCL - SSS/LDRI - Louvain Drug Research Institute, Thabault, Léopold, Liberelle, Maxime, and Frédérick, Raphaël
- Abstract
Protein self-association is a universal phenomenon essential for stability and molecular recognition. Disrupting constitutive homomers constitutes an original and emerging strategy in drug design. Inhibition of homomeric proteins can be achieved through direct complex disruption, subunits intercalation or by promoting inactive oligomeric states. Targeting self-interaction grants several advantages over active site inhibition thanks to the stimulation of protein degradation, the enhancement of selectivity, a sub-stoichiometric inhibition and a by-pass of compensatory mechanisms. This new landscape in protein inhibition is driven by the development of biophysical and biochemical tools suited for the study of homomeric proteins, such as DSF, native MS, FRET spectroscopy, two-dimensional NMR and X-ray crystallography. The present review covers the different aspects of this new paradigm in drug design.
- Published
- 2021